We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
The bootstrapping method was used to estimate average BG and corresponding HbA1c.
2
Subgroup analyses were done in diabetic patients according to their Hba1C levels.
3
HbA1c determinations were centralized in a Diabetes Control and Complications Trial-controlled laboratory.
4
The HbA1c is a really important test that we use all the time.
5
Conclusions: This study showed that HbA1c is a good predictor of in-hospital morbidity.
1
Some SMBG time points had a stronger association with A1C than others.
2
Higher levels of A1c suggest worse blood sugar control and possibly diabetes.
3
Blood pressure and hemoglobin A1c did not differ among the four groups.
4
They were more likely to document patient height, urinalyses results, and A1C values.
5
High A1C levels mean a high risk of complications from diabetes.
1
Blood pressure and hemoglobinA1c did not differ among the four groups.
2
BP and insulin resistance, reflected by hemoglobinA1c, were among cardiovascular risk factors.
3
Lipid profile, hemoglobinA1c and systemic blood pressure were measured in all patients.
4
Blood pressure, blood levels of hemoglobinA1c, and serum lipids were also measured.
5
These so-called hemoglobinA1c levels reflect average blood sugar levels over about three months.
1
Baseline BMI predicted greater fasting glucose and HgbA1c levels at 12 months for both treatments.
Usage of glycated hemoglobin in English
1
Primary outcome: We evaluated mean change in blood glycatedhemoglobin levels.
2
Glycemic control was based on glycatedhemoglobin levels and fasting blood glucose test.
3
Measurements and main results: We used admission glycatedhemoglobin to estimate premorbid baseline blood glucose concentration.
4
Higher total cholesterol, glycatedhemoglobin and insulin resistance parameters are connected with lower central dopamine tone.
5
Glucose-lowering therapies were granted regulatory approval primarily from smaller studies that have demonstrated reductions in glycatedhemoglobin concentration.
6
Top five factors in RF importance ranking were: waist, glucose, uric acid, and red cell distribution width and glycatedhemoglobin.
7
Between-group differences in blood pressure and glycatedhemoglobin levels during the trial were no longer evident by the first post-trial visit.
8
No correlation was seen between pancreatic volume index in patients and diabetes duration, glucose or C-peptide levels, glycatedhemoglobin, and islet autoantibodies.
9
The average duration of diagnosed diabetes was 10.8 years and the mean glycatedhemoglobin value was 10.8%.
10
Body mass index, blood pressure, fasting blood sugar, glycatedhemoglobin, lipid profile and antioxidants were measured at baseline and at every three months interval.
11
Aims: We describe a two-step screening approach using non-invasive risk assessment and glycatedhemoglobin (HbA1c) to identify participants for a diabetes prevention trial.
12
Individuals diagnosed with TB underwent glycatedhemoglobin (HbA1c) testing at the time of anti-tuberculous treatment initiation and at three -month follow up stage.
13
There was a trend towards greater T2D and hypertension remission rate after OAGB, while fasting glucose and glycatedhemoglobin levels were significantly lower after OAGB.
14
Changes in the glycatedhemoglobin (HbA1c) level after 3 months of treatment were compared with the baseline, and exploratory analysis was performed.
15
Glycatedhemoglobin is a measure of the patient's blood sugar control for the past two to three months.